Clinical Trial Update: Treatment of Angioedema Attacks in Adolescent and Adult Patients 12 Years and Older With HAE Type I or II With Sebetralstat

View source ↗

Summary

Regulatory approval for sebetralstat to treat angioedema attacks in adolescents and adults aged 12 years and older with hereditary angioedema types I or II, ena…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• Sebetralstat (Sebetralstat)

Snippet

Sponsor: KalVista Pharmaceuticals, Ltd. | Conditions: Hereditary Angioedema | Status: APPROVED_FOR_MARKETING